www.biotechcortex.com/2026/08/prec...
#science #biotechnolgy #biotechcortex

A global Phase 2 trial is testing TML-6, an investigational oral therapy for early Alzheimer's disease that targets the brain's own protein-clearing machinery rather than amyloid plaque directly.

#Alzheimers #Biotech #Biotechnolgy

Disclaimer: This is NOT a financial advice.